|
|||
Dr. David A. Barbie (Medical Oncology): A 62-year-old woman came to this hospital for management of breast cancer.
Six years earlier, a routine mammogram had revealed calcifications in the left breast. Specimens from a stereotactically guided core biopsy showed atypical cells, and an excisional biopsy with needle localization showed a grade 1 invasive ductal carcinoma of the left breast, 0.7 cm in maximal diameter, associated with intermediate-grade ductal carcinoma in situ. The tumor extended within 0.2 cm of the margin; there was no lymphovascular invasion. The tumor cells expressed estrogen and progesterone receptors and did not overexpress human epidermal growth
Differential Diagnosis
Pathological Discussion
Discussion of Management
Local Treatment of Contralateral Breast Cancer
Adjuvant Systemic Therapy for Breast Cancer
Assessing the Risks of Recurrence and Death from Breast Cancer
Adjuvant Endocrine Therapy
Adjuvant Chemotherapy
Trastuzumab in HER2-Positive Breast Cancer
Care of This Patient
Anatomical Diagnosis
Source Information
From the Departments of Medical Oncology (E.P.W.) and Radiation Oncology (J.R.H.), Dana–Farber Cancer Institute and Brigham and Women's Hospital; the Departments of Medicine (E.P.W.), Radiation Oncology (J.R.H.), Surgery (B.L.S.), Radiology (H.A.D.), and Pathology (E.F.B.), Harvard Medical School; and the Departments of Surgical Oncology (B.L.S.), Radiology (H.A.D.), and Pathology (E.F.B.), Massachusetts General Hospital — all in Boston.
Related Letters:
Case 32-2007: Bilateral Breast Cancer
Morrison P. J., Winer E. P., Harris J., Smith B. L.
Extract |
Full Text |
PDF
N Engl J Med 2008;
358:970, Feb 28, 2008.
Correspondence
This article has been cited by other articles:
HOME | SUBSCRIBE | SEARCH | CURRENT ISSUE | PAST ISSUES | COLLECTIONS | PRIVACY | TERMS OF USE | HELP | beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved. |